Table 1 Focus group questions
Question | CFIR Construct |
|---|---|
1. Prior to deciding to enroll in this study, describe your knowledge of, and experience with, pharmacogenetic (PGx) testing. | Evidence |
2. Based on your understanding of the literature, tell me your thoughts on the strength of the evidence behind PGx testing? a. What are your thoughts on how PGx testing might help you or your patients? | Evidence |
3. How do you feel that PGx testing compares to your usual approach to prescribing for depression? a. Do you see any advantages? Why or why not? | Relative Advantage |
4. To what extent do you feel you will incorporate the feedback from PGx testing in your prescribing for depression? b. What factors do you foresee influencing this? | Relative Advantage |
5. Specific to the PGx reports used in this study, what do you like about these reports? What do you not like? a. Are there other report formats you have seen, aside from the one we are using in this study? If so, what are your thoughts on how they compare? | Complexity, Intervention Design |
6. What barriers do you foresee to using PGx for depression prescribing? Do you have any concerns about using PGx? | Complexity |
7. What would help you to best use the PGx testing results? | Multiple |
8. Is there anything else related to the PGx testing/ study intervention that we haven’t discussed already that you feel is important? | Multiple |